AI assistant
ASSEMBLY BIOSCIENCES, INC. — Director's Dealing 2021
Apr 2, 2021
33081_dirs_2021-04-02_dd6d1e48-1abe-46dc-8260-f844405f46e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2021-03-29
Reporting Person: Delaney William E IV (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-29 | Common Stock | A | 11250 | $0.00 | Acquired | 56250 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-29 | Stock Option (right to buy) | $4.33 | A | 67500 | Acquired | 2031-03-29 | Common Stock (67500) | Direct |
Footnotes
F1: Grant of restricted stock units. The restricted stock units vest in four approximately equal installments, assuming continuous service on each vesting date, as follows: March 29, 2022; March 29, 2023; March 29, 2024; and March 29, 2025.
F2: Grant of stock options. The stock options vest over four years, assuming continuous service on each vesting date, as follows: 25% vest on the first anniversary of the date of grant, March 29, 2022; and the remaining 75% vest in 36 approximately equal monthly installments, with the options becoming fully vested on March 29, 2025.